<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35512359</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord.</ArticleTitle><Pagination><StartPage>3108</StartPage><EndPage>3130</EndPage><MedlinePgn>3108-3130</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awac165</ELocationID><Abstract><AbstractText>Aberrant self-assembly and toxicity of wild-type and mutant superoxide dismutase 1 (SOD1) has been widely examined in silico, in vitro and in transgenic animal models of amyotrophic lateral sclerosis. Detailed examination of the protein in disease-affected tissues from amyotrophic lateral sclerosis patients, however, remains scarce. We used histological, biochemical and analytical techniques to profile alterations to SOD1 protein deposition, subcellular localization, maturation and post-translational modification in post-mortem spinal cord tissues from amyotrophic lateral sclerosis cases and controls. Tissues were dissected into ventral and dorsal spinal cord grey matter to assess the specificity of alterations within regions of motor neuron degeneration. We provide evidence of the mislocalization and accumulation of structurally disordered, immature SOD1 protein conformers in spinal cord motor neurons of SOD1-linked and non-SOD1-linked familial amyotrophic lateral sclerosis cases, and sporadic amyotrophic lateral sclerosis cases, compared with control motor neurons. These changes were collectively associated with instability and mismetallation of enzymatically active SOD1 dimers, as well as alterations to SOD1 post-translational modifications and molecular chaperones governing SOD1 maturation. Atypical changes to SOD1 protein were largely restricted to regions of neurodegeneration in amyotrophic lateral sclerosis cases, and clearly differentiated all forms of amyotrophic lateral sclerosis from controls. Substantial heterogeneity in the presence of these changes was also observed between amyotrophic lateral sclerosis cases. Our data demonstrate that varying forms of SOD1 proteinopathy are a common feature of all forms of amyotrophic lateral sclerosis, and support the presence of one or more convergent biochemical pathways leading to SOD1 proteinopathy in amyotrophic lateral sclerosis. Most of these alterations are specific to regions of neurodegeneration, and may therefore constitute valid targets for therapeutic development.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trist</LastName><ForeName>Benjamin G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genoud</LastName><ForeName>Sian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roudeau</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Bordeaux, CNRS, CENBG, UMR 5797, F-33170 Gradignan, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rookyard</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdeen</LastName><ForeName>Amr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cottam</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hare</LastName><ForeName>Dominic J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Melbourne, Parkville 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Atomic Medicine Initiative, University of Technology Sydney, Broadway 2007, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altvater</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sydney Mass Spectrometry, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fifita</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grima</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6434-7706</Identifier><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kysenius</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville 3010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crouch</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville 3010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmona</LastName><ForeName>Asuncion</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Bordeaux, CNRS, CENBG, UMR 5797, F-33170 Gradignan, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rufin</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Plateforme Biochimie, University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claverol</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Plateforme Prot&#xe9;ome, University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Malderen</LastName><ForeName>Stijn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Deutsches Elektronen-Synchrotron DESY, Notkestr. 85, 22607 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falkenberg</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Deutsches Elektronen-Synchrotron DESY, Notkestr. 85, 22607 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Australian Synchrotron, ANSTO, Clayton 3168, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Bradley</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute and the Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 9RT London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troakes</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vance</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5780-6951</Identifier><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute and the Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 9RT London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sarraj</LastName><ForeName>Safa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>London Neurodegenerative Diseases Brain Bank, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 8AF London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordwell</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0422-8398</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1692-5406</Identifier><AffiliationInfo><Affiliation>University Bordeaux, CNRS, CENBG, UMR 5797, F-33170 Gradignan, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Double</LastName><ForeName>Kay L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0002-0712-399X</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">mislocalization</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">post-translational modifications</Keyword><Keyword MajorTopicYN="N">superoxide dismutase-1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>5</Day><Hour>17</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35512359</ArticleId><ArticleId IdType="pmc">PMC9473357</ArticleId><ArticleId IdType="doi">10.1093/brain/awac165</ArticleId><ArticleId IdType="pii">6580902</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA.. ALS genetics, mechanisms, and therapeutics: Where are we now? Front Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. . Mutations in Cu/Zn superoxide-dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature.1993;362:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Hilton JB, Hare DJ, Crouch PJ, Double KL. Superoxide dismutase 1 in health and disease: How a frontline antioxidant becomes neurotoxic. Angew Chem Int Ed Engl. 2021;60:9215&#x2013;9246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247289</ArticleId><ArticleId IdType="pubmed">32144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S, Cova E, Cereda C, et al. . An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci USA. 2012;109:5074&#x2013;5079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E, Takei YI, Ohara S, Fujiwara N, Hozumi I, Furukawa Y. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Mol Neurodegener. 2019;14:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6862823</ArticleId><ArticleId IdType="pubmed">31744522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, et al. . Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Welt T, Wirth F, et al. . A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci Transl Med. 2018;10:eaah3924.</Citation><ArticleIdList><ArticleId IdType="pubmed">30518612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B, Lehmann M, Beaudin M, et al. . Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018;8:14223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Graffmo K, Pakkenberg B, et al. . Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry. 2019;90:861&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, et al. . Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010;5:e11552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Bui A, Saberi S, et al. . Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 2017;134:97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, Liu H-N, Croul S, et al. . Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119:335&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">20111867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HN, Sanelli T, Horne P, et al. . Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2009;66:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">19670443</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Worp HB, Howells DW, Sena ES, et al. . Can animal models of disease reliably inform human studies? PLoS Med. 2010;7:e1000245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2846855</ArticleId><ArticleId IdType="pubmed">20361020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Destroismaisons L, Peyrard SL, et al. . Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum Mol Genet. 2013;22:3947&#x2013;3959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K, Allen SP, Mortiboys H, et al. . The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type. PLoS ONE. 2013;8:e68256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695905</ArticleId><ArticleId IdType="pubmed">23840839</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Hare DJ, Double KL. A proposed mechanism for neurodegeneration in movement disorders characterized by metal dyshomeostasis and oxidative stress. Cell Chem Biol. 2018;25:807&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">29861271</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Williams KL, Fifita JA, et al. . The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet. 2017;92:259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">28105640</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Davies KM, Cottam V, et al. . Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson&#x2019;s disease brain. Acta Neuropathol. 2017;134:113&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">28527045</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy CD, Venkaiah B. Purification and characterization of Cu, Zn-superoxide dismutases from mungbean (Vigna radiata) seedlings. J Biosci. 1984;6:115&#x2013;123.</Citation></Reference><Reference><Citation>Iqbal J, Whitney P. Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases. Free Radic Biol Med. 1991;10:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">1646752</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Johnson JA. Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics. 2010;7:471&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2967019</ArticleId><ArticleId IdType="pubmed">20880509</ArticleId></ArticleIdList></Reference><Reference><Citation>Roudeau S, Trist BG, Carmona A, et al. . Native separation and metallation analysis of SOD1 protein from the human central nervous system: A methodological workflow. Anal Chem. 2021;93:11108&#x2013;11115.</Citation><ArticleIdList><ArticleId IdType="pubmed">34348022</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoud S, Jones MWM, Trist BG, et al. . Simultaneous structural and elemental nano-imaging of human brain tissue. Chem Sci. 2020;11:8919&#x2013;8927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163372</ArticleId><ArticleId IdType="pubmed">34123146</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard DL, de Jonge MD, Afshar N, et al. . The XFM beamline at the Australian Synchrotron. J Synchrotron Radiat. 2020;27:1447&#x2013;1458.</Citation><ArticleIdList><ArticleId IdType="pubmed">32876622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan CG, Kirkham R, Hough RM, et al. . Elemental X-ray imaging using the Maia detector array: The benefits and challenges of large solid-angle. Nucl Instrum Methods Phys Res A. 2010;619:37&#x2013;43.</Citation></Reference><Reference><Citation>Ryan CG, Etschmann BE, Vogt S, et al. . Nuclear microprobe-synchrotron synergy: Towards integrated quantitative real-time elemental imaging using PIXE and SXRF. Nucl Instrum Methods Phys Res B. 2005;231:183&#x2013;188.</Citation></Reference><Reference><Citation>Kysenius K, Paul B, HIlton JB, Liddell JR, Hare DJ, Crouch PJ. A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samples. Anal Bioanal Chem. 2019:411:603&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">30218126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Khan H, Shahab U, et al. . Protein oxidation: An overview of metabolism of sulphur containing amino acid, cysteine. Front Biosci (Schol Ed). 2017;9:71&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">27814576</ArticleId></ArticleIdList></Reference><Reference><Citation>Rookyard AW, Paulech J, Thyssen S, et al. . A global profile of reversible and irreversible cysteine redox post-translational modifications during myocardial ischemia/reperfusion injury and antioxidant intervention. Antioxid Redox Signal. 2021;34:11&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513&#x2013;2526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Keilhauer EC, Geyer PE, Mann M. HCD fragmentation of glycated peptides. J Proteome Res. 2016;15:2881&#x2013;2890.</Citation><ArticleIdList><ArticleId IdType="pubmed">27425404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngamchuea K, Batchelor-McAuley C, Compton RG. Rapid method for the quantification of reduced and oxidized glutathione in human plasma and saliva. Anal Chem. 2017;89:2901&#x2013;2908.</Citation><ArticleIdList><ArticleId IdType="pubmed">28212001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S, Tsai S-M, Huang J-C, et al. . Effects of storage time and temperature on the stability of glutathione in deproteinized blood sample. J Food Drug Anal. 2006;14:141&#x2013;146.</Citation></Reference><Reference><Citation>Genoud S, Roberts BR, Gunn AP, et al. . Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson&#x2019;s disease brain. Metallomics. 2017;9:1447&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5647261</ArticleId><ArticleId IdType="pubmed">28944802</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xea; S, Josse J, Husson F. FactoMineR: An R package for multivariate analysis. J Stat Softw. 2008;25:1&#x2013;18.</Citation></Reference><Reference><Citation>Josse J, Husson F. missMDA: A package for handling missing values in multivariate data analysis. J Stat Softw. 2016;70:1&#x2013;31.</Citation></Reference><Reference><Citation>
Kassambara A, Mundt F. Factoextra: Extract and Visualize the Results of Multivariate Data Analyses. Version R Package Version 1.0.7. 2020. https://CRAN.R-project.org/package=factoextra</Citation></Reference><Reference><Citation>Wickham H, Averick M, Bryan J, et al. . Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686. 10.21105/joss.01686</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01686</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Boca M, et al. . Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc Natl Acad Sci USA. 2009;106:6980&#x2013;6985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678485</ArticleId><ArticleId IdType="pubmed">19369197</ArticleId></ArticleIdList></Reference><Reference><Citation>Culik RM, Sekhar A, Nagesh J, et al. . Effects of maturation on the conformational free-energy landscape of SOD1. Proc Natl Acad Sci USA. 2018;115:E2546&#x2013;E2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856554</ArticleId><ArticleId IdType="pubmed">29483249</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Aquilina JA, Yerbury JJ. Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity. Front Neurosci. 2016;10:499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095133</ArticleId><ArticleId IdType="pubmed">27867347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill C, Phelan JP, Hatzipetros T, et al. . SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Sci Rep. 2019;9:6724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491559</ArticleId><ArticleId IdType="pubmed">31040321</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA. Feb. 1995;92:954&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC42615</ArticleId><ArticleId IdType="pubmed">7862672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XF. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun. 2014;5:3446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678626</ArticleId><ArticleId IdType="pubmed">24647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RK, Fisher EM, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136:2342&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pergande MR, Cologna SM. Isoelectric point separations of peptides and proteins. Proteomes. 2017;5:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5372225</ArticleId><ArticleId IdType="pubmed">28248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Hart PJ, Borchelt DR, Andersen PM. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet. 2009;18:3217&#x2013;3226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BR, Lim NK, McAllum EJ, et al. . Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci. 2014;34:8021&#x2013;8031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks CJ, Andersen JL. Mechanisms of SOD1 regulation by post-translational modifications. Redox Biol. 2019;26:101270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658992</ArticleId><ArticleId IdType="pubmed">31344643</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan VK, Kerman A, Laister RC, Sharda PR, Arslan PE, Chakrabartty A. Early steps in oxidation-induced SOD1 misfolding: Implications for non-amyloid protein aggregation in familial ALS. J Mol Biol. 2012;421:631&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">22542526</ArticleId></ArticleIdList></Reference><Reference><Citation>Crown A, McAlary L, Fagerli E, et al. . Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection. PLoS ONE. 2020;15:e0227655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6991973</ArticleId><ArticleId IdType="pubmed">31999698</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolvahabi A, Shi Y, Rhodes NR, Cook NP, Marti AA, Shaw BF. Arresting amyloid with Coulomb&#x2019;s law: Acetylation of ALS-linked SOD1 by aspirin impedes aggregation. Biophys J. 2015;108:1199&#x2013;1212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375441</ArticleId><ArticleId IdType="pubmed">25762331</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Rhodes NR, Abdolvahabi A, et al. . Deamidation of asparagine to aspartate destabilizes Cu. Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations. J Am Chem Soc. 2013;135:15897&#x2013;15908.</Citation><ArticleIdList><ArticleId IdType="pubmed">24066782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii J, Myint T, Okado A, Kaneto H, Taniguchi N. Oxidative stress caused by glycation of Cu, Zn-superoxide dismutase and its effects on intracellular components. Nephrol Dial Transplant. 1996;11:34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">9044305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Takikawa M, Nakashima K, et al. . New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:163&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Schwartz D, Elias JE, et al. . A proteomics approach to understanding protein ubiquitination. Nat Biotechnol. 2003;21:921&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">12872131</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle C, Carri MT. Cysteine modifications in the pathogenesis of ALS. Front Mol Neurosci. 2017;10:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253364</ArticleId><ArticleId IdType="pubmed">28167899</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL, Wilcox KC, Proctor EA, Fee L, Caplow M, Dokholyan NV. Glutathionylation at Cys-111 induces dissociation of wild type and FALS mutant SOD1 dimers. Biochemistry. 2011;50:7057&#x2013;7066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281512</ArticleId><ArticleId IdType="pubmed">21739997</ArticleId></ArticleIdList></Reference><Reference><Citation>Toichi K, Yamanaka K, Furukawa Y. Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. J Biol Chem. 2013;288:4970&#x2013;4980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3576100</ArticleId><ArticleId IdType="pubmed">23264618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Cunningham P, Furtos-Matei A, et al. . Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem. 2002;277:47551&#x2013;47556.</Citation><ArticleIdList><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchinat E, Barbieri L, Banci L. A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants. Sci Rep. 2017;7:17433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5727297</ArticleId><ArticleId IdType="pubmed">29234142</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Barbieri L, Bertini I, et al. . Atomic-resolution monitoring of protein maturation in live human cells by NMR. Nat Chem Biol. 2013;9:297&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017183</ArticleId><ArticleId IdType="pubmed">23455544</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll MC, Girouard JB, Ulloa JL, et al. . Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. Proc Natl Acad Sci USA. 2004;101:5964&#x2013;5969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC395906</ArticleId><ArticleId IdType="pubmed">15069187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinato J, Iskandar M, L&#x2019;Abbe MR. Copper deficiency induces the upregulation of the copper chaperone for Cu/Zn superoxide dismutase in weanling male rats. J Nutr. 2003;133:28&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">12514262</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Ciofi-Baffoni S, Kozyreva T, Zovo K, Palumaa P. Affinity gradients drive copper to cellular destinations. Nature. 2010;465:645&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">20463663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelie HL, Liba A, Bourassa MW, et al. . Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J Biol Chem. 2011;286:2795&#x2013;2806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024775</ArticleId><ArticleId IdType="pubmed">21068388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward LJ, Rodriguez JA, Kim JW, et al. . Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2002;277:15923&#x2013;15931.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis. 2001;8:933&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd SD, Ullrich MS, Calvo JS, Behnia F, Meloni G, Winkler DD. Mutations in superoxide dismutase 1 (SOD1) linked to familial amyotrophic lateral sclerosis can disrupt high-affinity zinc-binding promoted by the copper chaperone for SOD1 (Ccs). Molecules. 2020;25:1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="pubmed">32121118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, Manfredi G.. Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space. Antioxid Redox Signal. 2010;13:1375&#x2013;1384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2962758</ArticleId><ArticleId IdType="pubmed">20367259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F, Ronchi D, Magri F, Comi GP, Corti S. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front Cell Neurosci. 2015;9:336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen Mojumdar S, N. Scholl Z, Dee DR, et al. . Partially native intermediates mediate misfolding of SOD1 in single-molecule folding trajectories. Nat Commun. 2017;8:1881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709426</ArticleId><ArticleId IdType="pubmed">29192167</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE, Li Y, Glass JD. Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro. Neurobiol Dis. 2013;49:49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549044</ArticleId><ArticleId IdType="pubmed">22926189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton J, White A, Crouch P. Metal-deficient SOD1 in amyotrophic lateral sclerosis. J Mol Med (Berl). 2015;93:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408375</ArticleId><ArticleId IdType="pubmed">25754173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102:170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirangelo I, Vella FM, Irace G, Manco G, Iannuzzi C. Glycation in demetalated superoxide dismutase 1 prevents amyloid aggregation and produces cytotoxic ages adducts. Front Mol Biosci. 2016;3:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5026054</ArticleId><ArticleId IdType="pubmed">27695694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Johnson JL, Agar NY, Agar JN. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 2008;6:e170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2486295</ArticleId><ArticleId IdType="pubmed">18666828</ArticleId></ArticleIdList></Reference><Reference><Citation>Capper MJ, Wright GSA, Barbieri L, et al. . The cysteine-reactive small molecule Ebselen facilitates effective SOD1 maturation. Nat Commun. 2018;9:1693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923229</ArticleId><ArticleId IdType="pubmed">29703933</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell NE, Yerbury MR, Plotkin SS, McAlary L, Yerbury JJ. CuATSM protects against the in vitro cytotoxicity of wild-type-like copper-zinc superoxide dismutase mutants but not mutants that disrupt metal binding. ACS Chem Neurosci. 2019;10:1555&#x2013;1564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30462490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>